At a glance
ClinicalIndex Comparison RecordN/ACompleted· 325 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
PASCONAL NERVENTROPFEN in the Treatment of Adults and Children Suffering From Nervous Diseases (e.g. Sleep Disorders Due to Nervousness)
In Brief
An observational study for Nervousness and Sleep Disorders. Completed, enrolled 325 participants across 1 site.
Detailed Summary
The purpose of this observational study is to give an overview of the use of PASCONAL NERVENTROPFEN in a 2-4 week treatment of nervous diseases, especially sleep disorders due to nervousness.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNervousness, Sleep Disorders
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2010
First PostedMay 2010
Primary CompletionOct 2010
TodayJul 2026
First PostedMay 18, 2010
Enrollment StartMay 1, 2010
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 16.1 years ago